According to a Centers for Disease Control and Prevention study, new cases of diabetes in the U.S. have began to decline, says the New York Times.» Read More
Teva said the stock-and-cash offer of $82 a share represented a 48 percent premium to Mylan's stock price on March 10.
Here are how some food-related stocks are moving on news of an avian flu outbreak in Iowa.
Just 68,000 people have signed up for HealthCare.gov plans during a grace period for those subject to an fine.
A new round of funding could propel small, data-driven health insurer Oscar into a major playing field for Obamacare plans.
Changes in the prescription drug market may have curbed prescription opioid abuse but may have also fueled a rise in heroin use.
Sofia Vergara's ex wants to prevent two frozen embryos they conceived from being destroyed now that they're broken up. What's the law here?
Biotech investors are going to be busy with new data on Alzheimer's drugs, cancer and genetic disorders on the way. Here's what analysts are watching.
Drugmaker Teva is considering making a bid for Mylan, but has not yet made a decision on an offer, Dow Jones reported.
For Pfizer and Merck, two big names that have ridden the merger wave, buying up more business is a possibility, their CEOs said.
A company says it can help states protect Obamacare subsidies for residents by setting up an insurance exchange in just two months.
After an abrupt departure, Former Teva CEO Jeremy Levin is now leading a start-up focused on rare neurological disorders.
Democrat Jared Bernstein says Chris Christie's Social Security plan "does virtually nothing" to make the program solvent.
Obamacare scared some companies, but their CEOs have been pleasantly surprised with how insurance prices have actually risen since 2011.
Thomas Terry has the "Best Job of 2015." And you know what question he gets asked all the time? "How long am I going to live?"
Wednesday's tax deadline features some new Obamacare-related chores that need to be completed.
Australia is making it harder for parents to file personal objections against vaccination.
After millions of people get hit with the Obamacare tax penalty, the real pain will hit. And it's a gift to Republicans, says Jake Novak.
IBM is teaming with Apple, J&J and Medtronic in hopes of revolutionizing the health care industry.
Johnson & Johnson reports quarterly earnings that beat expectations despite a 7.2 percent drag on the strong dollar.
The rate of people without health coverage has reached a record low, dropping to 11.9 percent since the launch of Obamacare.
Get the best of CNBC in your inbox